Hanfei Guo

537 total citations
22 papers, 326 citations indexed

About

Hanfei Guo is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Hanfei Guo has authored 22 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Hanfei Guo's work include Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (4 papers). Hanfei Guo is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Lung Cancer Research Studies (4 papers). Hanfei Guo collaborates with scholars based in China, United States and Kenya. Hanfei Guo's co-authors include Bin Wang, Hongquan Yu, Jiuwei Cui, Yong Chen, Gang Zhao, Lingyu Li, Lingyu Li, Haiyang Xu, Lei Qian and Wenqian Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and American Journal of Clinical Nutrition.

In The Last Decade

Hanfei Guo

19 papers receiving 324 citations

Peers

Hanfei Guo

ONCOL

PRM

IMMUN

Karim Mrouj France

Xusheng Chang China

Guilong Tanzhu China

Shengyu Wu China

Jindong Sheng China

Huirong Ding China

Tongguan Tian China

Rami Yacoub United States

Junko Zenkoh Japan

Karim Mrouj France

Hanfei Guo

173 ×1.3

102 ×0.9

ONCOL

59 ×0.7

PRM

70 ×1.5

33 ×0.9

IMMUN

Citations per year, relative to Hanfei Guo Hanfei Guo (= 1×) peers Karim Mrouj

Countries citing papers authored by Hanfei Guo

Since Specialization

Citations

This map shows the geographic impact of Hanfei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanfei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanfei Guo more than expected).

Fields of papers citing papers by Hanfei Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanfei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanfei Guo. The network helps show where Hanfei Guo may publish in the future.

Co-authorship network of co-authors of Hanfei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Hanfei Guo. A scholar is included among the top collaborators of Hanfei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanfei Guo. Hanfei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Lingyu, Wenqian Li, Dongsheng Xu, et al.. (2023). Association Between Visceral Fat Area and Cancer Prognosis: A Population-Based Multicenter Prospective Study. American Journal of Clinical Nutrition. 118(3). 507–517. 17 indexed citations

Guo, Hanfei, Bin Wang, Wenqian Li, Naifei Chen, & Jiuwei Cui. (2023). Current landscape and challenges ahead of immuno-molecular mechanism and immunotherapy strategy of brain metastases. 2(1).

Guo, Hanfei, Wenqian Li, Ye Guo, Naifei Chen, & Jiuwei Cui. (2023). Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation. Chinese Medical Journal. 137(2). 130–139. 4 indexed citations

Li, Wenqian, Rilan Bai, Hanfei Guo, & Jiuwei Cui. (2023). Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies. Chinese Medical Journal. 136(23). 2776–2786. 2 indexed citations

Zhao, Yijing, Hanfei Guo, & Ying‐Jun Chang. (2023). MRD-directed and risk-adapted individualized stratified treatment of AML. Chinese Journal of Cancer Research. 35(5). 451–469. 3 indexed citations

Li, Lingyu, Haiying Sun, Xiao Chen, et al.. (2023). Serum albumin as a prognostic predictor reflecting host immunity in patients with non–small cell lung cancer. 8(3). 136–142. 1 indexed citations

Wang, Bin, Hanfei Guo, Haiyang Xu, et al.. (2022). The Role of Graphene Oxide Nanocarriers in Treating Gliomas. Frontiers in Oncology. 12. 736177–736177. 20 indexed citations

Guo, Ye, Hanfei Guo, Yongfei Zhang, & Jiuwei Cui. (2022). Anaplastic lymphoma kinase-special immunity and immunotherapy. Frontiers in Immunology. 13. 908894–908894. 4 indexed citations

Li, Lingyu, Jiaxuan Li, Hua He, et al.. (2022). Clonal evolution characteristics and reduced dimension prognostic model for non-metastatic metachronous bilateral breast cancer. Frontiers in Oncology. 12. 963884–963884. 1 indexed citations

10.

Li, Wenqian, Hanfei Guo, Lingyu Li, & Jiuwei Cui. (2022). Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients. Frontiers in Oncology. 12. 858712–858712. 1 indexed citations

11.

Guo, Hanfei, Lei Qian, & Jiuwei Cui. (2021). Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome. Cancer Biology and Medicine. 18(-). 0–0. 14 indexed citations

12.

Wang, Bin, et al.. (2021). The Role of the Transcription Factor EGR1 in Cancer. Frontiers in Oncology. 11. 642547–642547. 155 indexed citations

13.

Li, Wenqian, Hanfei Guo, Lingyu Li, & Jiuwei Cui. (2021). Comprehensive Comparison Between Adjuvant Targeted Therapy and Chemotherapy for EGFR-Mutant NSCLC Patients: A Cost-Effectiveness Analysis. Frontiers in Oncology. 11. 619376–619376. 4 indexed citations

14.

Guo, Hanfei, Wenqian Li, Lei Qian, & Jiuwei Cui. (2021). Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer. Chinese Journal of Cancer Research. 33(2). 203–215. 8 indexed citations

15.

Guo, Hanfei, et al.. (2021). Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer?. Chinese Journal of Cancer Research. 33(5). 574–582. 5 indexed citations

16.

Guo, Hanfei, et al.. (2021). The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively. Cancer Medicine. 10(14). 4677–4696. 33 indexed citations

17.

Guo, Hanfei, Lei Qian, Xiao Chen, et al.. (2021). A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice. Open Medicine. 17(1). 53–60.

18.

Bai, Rilan, Zheng Lv, Chen Xiao, et al.. (2020). Precision Detection Technology: Equipping Precision Oncology with Wings. Journal of Oncology. 2020. 1–8. 5 indexed citations

19.

Guo, Hanfei, Lingyu Li, & Jiuwei Cui. (2020). Advances and challenges in immunotherapy of small cell lung cancer. Chinese Journal of Cancer Research. 32(1). 115–128. 23 indexed citations

20.

Guo, Hanfei, Rilan Bai, & Jiuwei Cui. (2020). [Advances in Combination Therapy of Immune Checkpoint Inhibitors for Lung Cancer].. SHILAP Revista de lepidopterología. 23(2). 101–110. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact